AAAAAA

   
Results: 1-10 |
Results: 10
ROLE OF POSTOPERATIVE CHEMOTHERAPY (CT) IN RADICALLY RESECTED RESIDUAL CANCER (CA) IN ADVANCED NON SEMINOMATOUS GERM-CELL TUMORS (NSGCT) INTHE MALE
Authors: PIZZOCARO G SALVIONI R NICOLAI N PIVA L MILANI A MERSON M COLAVITA M
Citation: G. Pizzocaro et al., ROLE OF POSTOPERATIVE CHEMOTHERAPY (CT) IN RADICALLY RESECTED RESIDUAL CANCER (CA) IN ADVANCED NON SEMINOMATOUS GERM-CELL TUMORS (NSGCT) INTHE MALE, The Journal of urology, 159(5), 1998, pp. 173-173
ADJUVANT AND NEOADJUVANT CHEMOTHERAPY FOR NODAL METASTASES FROM SQUAMOUS-CELL CARCINOMA (SCC) OF THE PENIS
Authors: PIZZOCARO G PIVA L NICOLAI N
Citation: G. Pizzocaro et al., ADJUVANT AND NEOADJUVANT CHEMOTHERAPY FOR NODAL METASTASES FROM SQUAMOUS-CELL CARCINOMA (SCC) OF THE PENIS, European journal of cancer, 31A, 1995, pp. 472-472
DOSE INTENSITY IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)OF THE TESTIS TREATED WITH FIRST-LINE CISPLATIN, ETOPOSIDE, BLEOMYCIN(PEB) AND RESECTION OF THE RESIDUAL MASS
Authors: PIZZOCARO G MARIANI L NICOLAI N SALVIONI R
Citation: G. Pizzocaro et al., DOSE INTENSITY IN METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT)OF THE TESTIS TREATED WITH FIRST-LINE CISPLATIN, ETOPOSIDE, BLEOMYCIN(PEB) AND RESECTION OF THE RESIDUAL MASS, European journal of cancer, 31A, 1995, pp. 917-917
POSTORCHIECTOMY MARKERS ELEVATION ONLY IN NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT) OF THE TESTIS
Authors: PIZZOCARO G NICOLAI N PIVA L SALVIONI R
Citation: G. Pizzocaro et al., POSTORCHIECTOMY MARKERS ELEVATION ONLY IN NONSEMINOMATOUS GERM-CELL TUMORS (NSGCT) OF THE TESTIS, European journal of cancer, 31A, 1995, pp. 918-918
THE ROLE OF ADJUVANT TREATMENT IN LOW-STAGE GERM-CELL TESTICULAR-TUMORS
Authors: PIZZOCARO G SALVIONI R NICOLAI N
Citation: G. Pizzocaro et al., THE ROLE OF ADJUVANT TREATMENT IN LOW-STAGE GERM-CELL TESTICULAR-TUMORS, European urology, 28(4), 1995, pp. 267-272
A SURVEILLANCE STUDY OF CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - 10-YEAR FOLLOW-UP
Authors: NICOLAI N PIZZOCARO G
Citation: N. Nicolai et G. Pizzocaro, A SURVEILLANCE STUDY OF CLINICAL STAGE-I NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - 10-YEAR FOLLOW-UP, The Journal of urology, 154(3), 1995, pp. 1045-1049
EVOLUTION AND CONTROVERSIES IN THE MANAGEMENT OF LOW-STAGE NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
Authors: PIZZOCARO G NICOLAI N SALVIONI R
Citation: G. Pizzocaro et al., EVOLUTION AND CONTROVERSIES IN THE MANAGEMENT OF LOW-STAGE NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS, World journal of urology, 12(3), 1994, pp. 113-119
MULTIPHASE STRUCTURE - A CHANCE FOR EXTEN SIVE CHANGES OF PROPERTIES - MIXING AND FLOW BEHAVIOR OF MULTIPHASE BLENDS
Authors: KOLZSCH N STARKE L NICOLAI N SCHULZE V MOOS KH
Citation: N. Kolzsch et al., MULTIPHASE STRUCTURE - A CHANCE FOR EXTEN SIVE CHANGES OF PROPERTIES - MIXING AND FLOW BEHAVIOR OF MULTIPHASE BLENDS, Kunststoffe, German plastics, 83(9), 1993, pp. 681-686
DEXAMETHASONE PLUS ONDANSETRON VERSUS DEXAMETHASONE PLUS ALIZAPRIDE IN THE PREVENTION OF EMESIS INDUCED BY CISPLATIN-CONTAINING CHEMOTHERAPIES FOR UROLOGICAL CANCERS
Authors: NICOLAI N MANGIAROTTI B SALVIONI R PIVA L FAUSTINI M PIZZOCARO G
Citation: N. Nicolai et al., DEXAMETHASONE PLUS ONDANSETRON VERSUS DEXAMETHASONE PLUS ALIZAPRIDE IN THE PREVENTION OF EMESIS INDUCED BY CISPLATIN-CONTAINING CHEMOTHERAPIES FOR UROLOGICAL CANCERS, European urology, 23(4), 1993, pp. 450-456
MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS
Authors: PIZZOCARO G SALVIONI R PIVA L FAUSTINI M NICOLAI N GIANNI L
Citation: G. Pizzocaro et al., MODIFIED CISPLATIN, ETOPOSIDE (OR VINBLASTINE) AND IFOSFAMIDE SALVAGETHERAPY FOR MALE GERM-CELL TUMORS - LONG-TERM RESULTS, Annals of oncology, 3(3), 1992, pp. 211-216
Risultati: 1-10 |